Proposed Data Collection Submitted for Public Comment and Recommendations, 32704-32705 [2017-14914]
Download as PDF
<![CDATA[
32704
Federal Register / Vol. 82, No. 135 / Monday, July 17, 2017 / Notices
There are no costs to the responders
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
Receptionist ............................................................................
Occupational health and safety specialists .............................
Industrial Production Managers ..............................................
Natural Sciences Managers ....................................................
Pre-call ...................................
Survey ....................................
Survey ....................................
Survey ....................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–14912 Filed 7–14–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–17–17AMP; Docket No. CDC–2017–
0057]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice with comment period.
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection entitled ‘‘Evaluation of the
SAMHSA Naloxone Education and
Distribution Program.’’ CDC will use the
information collected to evaluate the
program ‘‘Substance Abuse and Mental
Health Services Agency (SAMHSA)
Grants to Prevent Prescription Drug/
Opioid Overdose-Related Deaths.’’ The
program was recently funded to
improve access to treatment for opioid
use disorders, reduce opioid related
deaths, and strengthen drug misuse
prevention efforts.
SUMMARY:
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Number of
respondents
VerDate Sep<11>2014
17:45 Jul 14, 2017
Jkt 241001
Written comments must be
received on or before September 15,
2017.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2017–
0057 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment
should be submitted through the
Federal eRulemaking portal
(Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact LeRoy A.
Richardson, Information Collection
Review Office, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE., MS–D74, Atlanta, Georgia
30329; phone: 404–639–7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
DATES:
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
300
100
75
75
1
1
1
1
Avgerage
burden per
response
(in hours)
5/60
20/60
20/60
20/60
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Evaluation of the SAMHSA Naloxone
Education and Distribution Program—
New—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
E:\FR\FM\17JYN1.SGM
17JYN1
32705
Federal Register / Vol. 82, No. 135 / Monday, July 17, 2017 / Notices
Background and Brief Description
Overdose deaths involving
prescription opioids and heroin have
reached epidemic levels in the U.S. and
continue to rise. To address the
prescription drug/opioid overdose
crisis, the federal government has
recently allocated funding to improve
access to treatment for opioid use
disorders, reduce opioid related deaths,
and strengthen drug misuse prevention
efforts. One program resulting from the
federal government’s efforts to address
the opioid crisis is, the Substance Abuse
and Mental Health Services Agency
(SAMHSA) Grants to Prevent
Prescription Drug/Opioid OverdoseRelated Deaths (PDO/naloxone grant).
This collection will be to evaluate the
Substance Abuse and Mental Health
Services Agency (SAMHSA) Grants to
Prevent Prescription Drug/Opioid
Overdose-Related Deaths.
This evaluation will seek to describe
and understand the scope and impact of
the program on overdose. To address the
prescription drug/opioid overdose
The intended use of the resulting data
is to increase CDC and SAMHSA
understanding of the scope and impact
of the program on overdose fatalities
and how program effectiveness may
vary among different sub-populations
and settings, and to increase knowledge
of barriers and facilitators to program
implementation. Key informant
interviews and focus groups with
participants in the activities enacted by
the twelve state grant recipients will be
methodology used. This will include
state administrators of the grant and
other PDO/Naloxone stakeholders
including advisory council members,
first responders, social service
providers, laypersons including end
users and their family and friend. All
focus groups and interviews will be
analyzed through qualitative content
analysis, including utilization of a
systematic coding scheme.
Total burden in hours for this
collection is 381. There are no costs to
respondents other than their time.
crisis, the federal government has
recently allocated funding to improve
access to treatment for opioid use
disorders, reduce opioid related deaths,
and strengthen drug misuse prevention
efforts. One program resulting from the
federal government’s efforts to address
the opioid crisis is, the Substance Abuse
and Mental Health Services Agency
(SAMHSA) Grants to Prevent
Prescription Drug/Opioid OverdoseRelated Deaths (PDO/naloxone grant).
Through this program, SAMHSA
awarded funding to 12 states. The
funding is aimed at reducing the
number of prescription drug/opioid
overdose-related deaths and adverse
events among individuals 18 years of
age and older through educating and
training first responders and other key
community sectors on the prevention of
prescription drug/opioid overdoserelated deaths, including the purchase
and distribution of naloxone. SAMHSA
is funding the grant and CDC is
responsible for conducting the grantee
evaluation.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Form name
PDO/Naloxone Advisory Committee
Members and Grantees.
PDO/Naloxone Grantees ..................
Focus Group Discussion Guide .......
140
1
1.5
210
Individual
Interview
Discussion
Guide for Grantees.
Individual
Interview
Discussion
Guide for Partners.
Individual
Interview
Discussion
Guide for Laypersons.
Recruitment contact script ...............
36
1
1
36
84
1
1
84
24
1
1
24
284
1
5/60
24
Key Informant Selection Tool ...........
12
1
15/60
3
...........................................................
........................
........................
........................
381
PDO/Naloxone Stakeholders and
Partners.
PDO/Naloxone Laypersons ..............
All participants (PDO Naloxone
grantees, advisory committee,
stakeholders
and
partners,
laypersons).
PDO/Naloxone Grantees ..................
Total ...........................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–14914 Filed 7–14–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–17–1054; Docket No. CDC–2017–
0055]
asabaliauskas on DSKBBXCHB2PROD with NOTICES
BILLING CODE 4163–18–P
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
SUMMARY:
VerDate Sep<11>2014
17:45 Jul 14, 2017
Jkt 241001
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection entitled ‘‘Drug Overdose
Response Investigation (DORI) Data
Collections.’’ CDC will use the
information collected to respond to
urgent requests from state and local
health authorities to provide
epidemiological information that allows
E:\FR\FM\17JYN1.SGM
17JYN1
]]>Agencies
[Federal Register Volume 82, Number 135 (Monday, July 17, 2017)]
[Notices]
[Pages 32704-32705]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-14914]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-17-17AMP; Docket No. CDC-2017-0057]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection entitled ``Evaluation of the SAMHSA Naloxone
Education and Distribution Program.'' CDC will use the information
collected to evaluate the program ``Substance Abuse and Mental Health
Services Agency (SAMHSA) Grants to Prevent Prescription Drug/Opioid
Overdose-Related Deaths.'' The program was recently funded to improve
access to treatment for opioid use disorders, reduce opioid related
deaths, and strengthen drug misuse prevention efforts.
DATES: Written comments must be received on or before September 15,
2017.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0057 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact LeRoy A. Richardson, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE., MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services
to provide information. Burden means the total time, effort, or
financial resources expended by persons to generate, maintain, retain,
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; to develop, acquire,
install and utilize technology and systems for the purpose of
collecting, validating and verifying information, processing and
maintaining information, and disclosing and providing information; to
train personnel and to be able to respond to a collection of
information, to search data sources, to complete and review the
collection of information; and to transmit or otherwise disclose the
information.
Proposed Project
Evaluation of the SAMHSA Naloxone Education and Distribution
Program--New--National Center for Injury Prevention and Control
(NCIPC), Centers for Disease Control and Prevention (CDC).
[[Page 32705]]
Background and Brief Description
Overdose deaths involving prescription opioids and heroin have
reached epidemic levels in the U.S. and continue to rise. To address
the prescription drug/opioid overdose crisis, the federal government
has recently allocated funding to improve access to treatment for
opioid use disorders, reduce opioid related deaths, and strengthen drug
misuse prevention efforts. One program resulting from the federal
government's efforts to address the opioid crisis is, the Substance
Abuse and Mental Health Services Agency (SAMHSA) Grants to Prevent
Prescription Drug/Opioid Overdose-Related Deaths (PDO/naloxone grant).
This collection will be to evaluate the Substance Abuse and Mental
Health Services Agency (SAMHSA) Grants to Prevent Prescription Drug/
Opioid Overdose-Related Deaths.
This evaluation will seek to describe and understand the scope and
impact of the program on overdose. To address the prescription drug/
opioid overdose crisis, the federal government has recently allocated
funding to improve access to treatment for opioid use disorders, reduce
opioid related deaths, and strengthen drug misuse prevention efforts.
One program resulting from the federal government's efforts to address
the opioid crisis is, the Substance Abuse and Mental Health Services
Agency (SAMHSA) Grants to Prevent Prescription Drug/Opioid Overdose-
Related Deaths (PDO/naloxone grant). Through this program, SAMHSA
awarded funding to 12 states. The funding is aimed at reducing the
number of prescription drug/opioid overdose-related deaths and adverse
events among individuals 18 years of age and older through educating
and training first responders and other key community sectors on the
prevention of prescription drug/opioid overdose-related deaths,
including the purchase and distribution of naloxone. SAMHSA is funding
the grant and CDC is responsible for conducting the grantee evaluation.
The intended use of the resulting data is to increase CDC and
SAMHSA understanding of the scope and impact of the program on overdose
fatalities and how program effectiveness may vary among different sub-
populations and settings, and to increase knowledge of barriers and
facilitators to program implementation. Key informant interviews and
focus groups with participants in the activities enacted by the twelve
state grant recipients will be methodology used. This will include
state administrators of the grant and other PDO/Naloxone stakeholders
including advisory council members, first responders, social service
providers, laypersons including end users and their family and friend.
All focus groups and interviews will be analyzed through qualitative
content analysis, including utilization of a systematic coding scheme.
Total burden in hours for this collection is 381. There are no
costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
PDO/Naloxone Advisory Focus Group 140 1 1.5 210
Committee Members and Discussion
Grantees. Guide.
PDO/Naloxone Grantees......... Individual 36 1 1 36
Interview
Discussion
Guide for
Grantees.
PDO/Naloxone Stakeholders and Individual 84 1 1 84
Partners. Interview
Discussion
Guide for
Partners.
PDO/Naloxone Laypersons....... Individual 24 1 1 24
Interview
Discussion
Guide for
Laypersons.
All participants (PDO Naloxone Recruitment 284 1 5/60 24
grantees, advisory committee, contact script.
stakeholders and partners,
laypersons).
PDO/Naloxone Grantees......... Key Informant 12 1 15/60 3
Selection Tool.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 381
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-14914 Filed 7-14-17; 8:45 am]
BILLING CODE 4163-18-P
